FENC Q1 2022 Earnings — Fennec Pharmaceuticals Inc. Revenue & Financial Results | Market Cap Arena

FENCFennec Pharmaceuticals Inc.

$220M

Q1 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$7,085

Operating Income

-$4M

Net Income

-$4M

EPS (Diluted)

$-0.15

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$3M

Free Cash Flow

-$3M

Stock-Based Comp.

$399,000

Balance Sheet

Total Assets

$19M

Total Liabilities

$7M

Stockholders' Equity

$13M

Cash & Equivalents

$18M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$7,085	$0	—
Operating Income	-$4M	-$5M	+27.5%
Net Income	-$4M	-$5M	+21.5%